Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03721393
Other study ID # C2109
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 4, 2019
Est. completion date May 8, 2023

Study information

Verified date August 2023
Source Boston Scientific Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To characterize the impact of orthostatic hypotension (OH) and reflex syncope on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of signals measured from the wearable cardiac monitor prototype device with reported symptom severity of orthostatic intolerance per standard data collection, analysis, and questionnaires.


Description:

This is a non-randomized feasibility study that will enroll up to 50 participants that have undergone a previous autonomic reflect screen (ARS) assessment and were either diagnosed with OH or reflex syncope, or considered to be control subjects for this study. A maximum of 20 subjects diagnosed with reflex syncope, a maximum of 10 subjects diagnosed with OH and a maximum of 10 control subjects will be enrolled. There will be one study visit per subject.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 8, 2023
Est. primary completion date May 8, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Willing and capable to provide informed consent - Age 18 or above - No contraindications to undergo tilt table test, Valsalva maneuver test, and deep breathing test (Components of the ARS assessment) - Previously underwent a clinically indicated ARS assessment without complications (including deep breathing, Valsalva maneuver, and tilt table testing). Previously diagnosed with OH, reflex syncope, OR control subjects assessed as normal, based on the ARS assessment. Patient enrollment shall be based on the type of diagnosis. - Willing to participate in one additional tilt table test, Valsalva maneuver test, and deep breathing test (components of the ARS assessment) Exclusion Criteria: - Currently enrolled in another clinical trial that might interfere with data collection. - Subject is pregnant or planning to become pregnant during the study - Active Implantable Medical Device, e.g. cardiac implantable electronic devices, bladder stimulators, diaphragm stimulators, implantable neuro stimulator, implantable active monitoring devices, implantable active drug administration devices, etc. - Have a prosthetic cardiac valve or previously underwent cardiac valve surgery. - Known allergy to materials used in the study (adhesive, ECG electrodes) - Diagnosed with syncope due to cardiologic causes. - Have had a myocardial infarction in the previous 90 days - Have been diagnosed with tachycardia that requires medical treatment - Experienced complications during previous clinically indicated ARS assessment - Are on medications that could affect autonomic function, if considered not safe or unwilling to hold such medications for at least four half-lives prior to testing (judged by the study Principal Investigator) - Have any contraindication for tilt test, Valsalva maneuver test or deep breathing test

Study Design


Intervention

Device:
Wearable heart monitor
Participants will be fitted with a wearable heart monitor placed on the skin that measures physiologic signals. There is no intervention or treatment.

Locations

Country Name City State
United States Mayo Clinic Foundation Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Boston Scientific Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physiologic Signal Detection Characterize the impact of orthostatic hypotension (OH) and reflex syncope on physiologic signals measured using a wearable cardiac monitor prototype device. 12 months
See also
  Status Clinical Trial Phase
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Recruiting NCT05941819 - ARC Therapy to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT02897063 - Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Phase 1
Completed NCT02726776 - Suspension Syndrome N/A
Completed NCT01559675 - Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery N/A
Not yet recruiting NCT04440085 - RaGuS Trial by Postoperative Patients Phase 4
Recruiting NCT03732716 - Sarcopenia and Orthostatic Hypotension
Recruiting NCT05621460 - The Effect of Water Carbonation on Orthostatic Tolerance N/A
Completed NCT02632318 - Dawn Simulation and Postural Hypotension Phase 4
Completed NCT05729724 - Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
Completed NCT01030874 - Orthostatic Hypotension Treatment on Rehab Unit N/A
Completed NCT01223391 - Abdominal Compression in Orthostatic Hypotension N/A
Completed NCT01362751 - Orthostatic Hypotension in Elderly Nursing Home Residents N/A
Completed NCT00248807 - A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury. N/A
Terminated NCT00137319 - Impedance Threshold Device Tilt Study N/A
Completed NCT05233865 - Hemodynamic Effects During Land vs Water Exercise for Older Adults With Orthostatic Hypotension N/A
Suspended NCT01370512 - Droxidopa / Pyridostigmine in Orthostatic Hypotension Phase 2
Recruiting NCT00452712 - Orthostatic Hypotension in Children With Acute Febrile Illness Phase 2
Recruiting NCT04493372 - Deciphering Preserved Autonomic Function After Spinal Cord Injury N/A